Table of Contents
Quick answer
Place affected stock on hold under its labelled storage conditions, preserve the original logger data and identify the product, lots and exposure window. Request a product-specific assessment from the responsible quality function. Neither an alarm nor a normal-looking product alone establishes whether stock can be released.
The shipment is on the receiving bench and the logger shows an alarm. Before asking whether the goods are usable, establish what the alarm means for this product and this journey. Its threshold may reflect a shipping specification, a default logger setting or a setup error; the original data and configuration are needed to distinguish them.
The receiving team’s immediate job is to preserve the evidence and keep the affected stock controlled. Product disposition should follow an appropriate, documented quality assessment.
What should happen after a medical device temperature excursion alarm?
Identify the affected shipment and lots, apply a hold status under your procedure and maintain the product’s labelled storage conditions while the concern is reviewed. Avoid improvising a different temperature treatment in an attempt to “reverse” the exposure.
Retain the transport packaging and photograph the arrival condition where relevant. Record when the shipment was received, when the logger was read and who performed the check. These simple observations help connect the temperature record to the physical handoff.
Do not dispatch the stock while the release question is unresolved. Equally, do not describe the entire shipment as damaged solely because an alarm appeared. Preserve the distinction between an observed signal and an established product impact.
Which logger details make an investigation possible?
Keep the original exported file and the information needed to interpret it. A cropped screenshot can be useful for communication but should not become the only retained evidence.
| Evidence | What to capture | Why it matters |
|---|---|---|
| Logger identity | Device ID and applicable calibration information | Links the record to the instrument |
| Configuration | Sampling interval, alarm settings and start/stop details | Explains what was recorded and flagged |
| Time basis | Time zone, clock setting and journey milestones | Aligns exposure with handoffs |
| Placement | Location in the package and packing arrangement | Helps assess what the measurement represents |
| Exposure record | Full time series and relevant events | Preserves duration and pattern, not only the peak |
| Product identity | Model, lots, quantities and labelled requirements | Defines the scope of the assessment |
WHO’s model guidance for temperature-sensitive pharmaceutical products offers a useful reference for monitoring and storage-system thinking. Its pharmaceutical scope must be respected: it does not establish the permitted temperature range for a particular aesthetic device.
Why are the peak temperature and appearance insufficient?
A peak does not describe the full exposure history, and visual appearance does not establish all relevant product attributes. The responsible reviewer needs the duration, sequence, product configuration and applicable evidence, not just a yes/no alarm.
FDA’s PMA discussion of shelf life connects expiration dating to labelled storage instructions and supporting stability evidence in that regulatory context. Buyers should request a product-specific assessment rather than treating a general statement about stability as permission for an unreviewed excursion.
For example, an alarm recorded before packing is a different investigative scenario from one that spans the main transport leg. The distinction may change which evidence is needed, but it should be established from records rather than assumed because the carton feels cool at receipt.
What should the supplier’s response resolve?
It should identify the reviewed product and lots, the exposure record considered, the relevant assessment basis and the proposed disposition. A response saying “this usually happens” does not connect the decision to the actual shipment.
Ask who within the responsible quality function authorized the conclusion and how any conditions apply to the stock. Keep the decision attached to the receiving record. If only part of the shipment is covered, leave the remaining scope explicit.
An unresolved data gap should remain a gap. Do not interpolate missing hours as normal temperature, delete alarm intervals or substitute a nearby shipment’s logger record. If additional information cannot be recovered, the disposition must address that uncertainty.
How does the incident improve the next shipment?
Review the route, packaging configuration, logger setup and handoff timing after the immediate stock decision. Look for a correctable process issue rather than automatically ordering more refrigerant or selecting a colder service.
The cold-chain and air-freight guide addresses planning before dispatch. Feed the findings back into that plan: the exact monitoring setup, responsible contacts, required arrival records and response to an alarm. This closes the loop between shipping arrangements and the evidence needed at receipt.
Keep the shipment lot identifiers aligned with the batch document review. A satisfactory COA cannot by itself resolve a later transport excursion.
Frequently Asked Questions
Does every aesthetic product require refrigerated shipping?
No. Use the storage and transport requirements for the specific product and configuration. Do not borrow a temperature range from a different filler, pharmaceutical product or shipping example.
Can the receiving team reset the logger after taking a screenshot?
Preserve the original export and identifying information first, following the device and quality procedures. A screenshot may omit intervals, configuration or timestamps needed to reconstruct the exposure.
Sources
- Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products — World Health Organization (2011-08-02)
- PMA Special Considerations — U.S. FDA
